Metyrapone

FDA Drug Profile — Metopirone

Metyrapone is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Metopirone. Available dosage forms: powder, capsule, gelatin coated.

Drug Details

Generic Name
Metyrapone
Brand Names
Metopirone
Application Number
NDA012911
Sponsor
Minakem Beuvry Production
NDC Codes
3
Dosage Forms
POWDER, CAPSULE, GELATIN COATED
Routes
ORAL
Active Ingredients
METYRAPONE

Indications and Usage

1 INDICATIONS AND USAGE Metopirone is indicated, in combination with other diagnostic tests, for the diagnosis of adrenal insufficiency in adult and pediatric patients. Metopirone is indicated, in combination with other diagnostic tests, for the diagnosis of adrenal insufficiency in adult and pediatric patients. ( 1 )